It's important to know your AML subtype because it plays a large part in determining the type of treatment you'll receive.
World Health Organization (WHO) Classification System
The World Health Organization (WHO) classification is the main system used to classify AML into subtypes. It includes prognostic (predictive) factors, such as chromosomal abnormalities and genetic mutations, which are known to affect the future outcome of the cancer. These genetic factors help provide patients and their doctors with more reliable information regarding their probable outcome (prognosis), as well as how they are likely to respond to treatment.
The table below is based on the World Health Organization (WHO) classification. Abbreviations: t, a translocation between chromosomes; inv, an inversion in a chromosome; q, the long arm of a chromosome (the lower half); p, the short arm of a chromosome (the upper half).